Abstract:Against the backdrop of deepening implementation of the innovation-driven development strategy and strengthened mechanisms for intellectual property protection and commercialisation, high-value patents have emerged as a key indicator of a company"s core innovation capabilities and market competitiveness. Concurrently, while merger and acquisition (M&A) activity in China"s capital markets has intensified, issues of M&A premium pricing deviations and information asymmetry remain prominent. Drawing upon data from Chinese A-share listed companies spanning 2007 to 2023, this study empirically examines the impact of high-value patents on M&A premiums. Research indicates that high-value patents exert a significant positive influence on M&A premiums. By heightening analyst attention and curbing earnings management practices, these patents enhance external investors" recognition of a firm"s innovative value, thereby elevating M&A premiums. Managerial overconfidence diminishes the positive effect of high-value patents, whereas entering into performance compensation commitments amplifies this impact. Heterogeneity tests indicate this effect is more pronounced when the acquiring firm has low CEO reputation or operates in a highly competitive sector. The findings provide empirical evidence for firms seeking to enhance M&A pricing power through cultivating high-value patents, while also offering policy implications for governments aiming to refine innovation valuation frameworks and capital market regulatory mechanisms.